Congenital carnitine deficiency

Also known as: Primary Carnitine deficiency / Systemic primary carnitine deficiency / Renal carnitine transport defect (disorder)

Drug	Drug Name	Drug Description
DB00583	Levocarnitine	A quaternary ammonium compound used to treat carnitine deficiency or to stimulate gastric and pancreatic secretions in hyperlipoproteinemia.

Drug	Drug Name	Target	Type
DB00583	Levocarnitine	Carnitine O-palmitoyltransferase 1, liver isoform	target
DB00583	Levocarnitine	Solute carrier family 22 member 4	target
DB00583	Levocarnitine	Solute carrier family 22 member 5	target
DB00583	Levocarnitine	Carnitine O-acetyltransferase	target
DB00583	Levocarnitine	Mitochondrial carnitine/acylcarnitine carrier protein CACL	target
DB00583	Levocarnitine	Mitochondrial carnitine/acylcarnitine carrier protein	target
DB00583	Levocarnitine	Peroxisomal carnitine O-octanoyltransferase	target
DB00583	Levocarnitine	Carnitine O-palmitoyltransferase 2, mitochondrial	target
DB00583	Levocarnitine	Solute carrier family 22 member 4	transporter
DB00583	Levocarnitine	Solute carrier organic anion transporter family member 1B1	transporter
DB00583	Levocarnitine	Solute carrier family 22 member 5	transporter
DB00583	Levocarnitine	Solute carrier family 22 member 16	transporter
DB00583	Levocarnitine	Solute carrier family 22 member 8	transporter
DB00583	Levocarnitine	Xanthine dehydrogenase/oxidase	target
DB00583	Levocarnitine	Liver carboxylesterase 1	target
DB00583	Levocarnitine	Myeloperoxidase	target

Drug	Drug Name	Phase	Status	Count